A Bertasso

648 total citations
22 papers, 447 citations indexed

About

A Bertasso is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, A Bertasso has authored 22 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in A Bertasso's work include HIV Research and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). A Bertasso is often cited by papers focused on HIV Research and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). A Bertasso collaborates with scholars based in United States, United Kingdom and Switzerland. A Bertasso's co-authors include N H Georgopapadakou, John Pace, Jack Chapman, Willi Kreis, Andrea Baker, Stefan Zeuzem, Isabel Nájera, Michael Rabbia, J P Caulfield and Cristiano A. F. Zerbini and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

A Bertasso

22 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Bertasso United States 14 143 141 121 115 100 22 447
Susan Chaniewski United States 7 161 1.1× 244 1.7× 265 2.2× 52 0.5× 25 0.3× 10 378
Sanjay Khandekar United States 7 59 0.4× 81 0.6× 47 0.4× 396 3.4× 22 0.2× 11 683
Joan Zugay-Murphy United States 8 130 0.9× 44 0.3× 55 0.5× 202 1.8× 20 0.2× 9 363
Xinfeng Xu China 16 105 0.7× 80 0.6× 15 0.1× 155 1.3× 88 0.9× 40 584
Muhammad Hasan United States 9 76 0.5× 192 1.4× 150 1.2× 61 0.5× 5 0.1× 15 394
Inna L. Karpenko Russia 16 217 1.5× 194 1.4× 49 0.4× 282 2.5× 11 0.1× 43 607
Phisit Prapunwattana Thailand 15 142 1.0× 127 0.9× 26 0.2× 285 2.5× 12 0.1× 22 638
M Zawada Poland 8 81 0.6× 60 0.4× 16 0.1× 131 1.1× 42 0.4× 23 329
Juliane Gentzsch Germany 12 51 0.4× 244 1.7× 292 2.4× 119 1.0× 3 0.0× 12 523
Aditya Venugopal United States 8 306 2.1× 321 2.3× 53 0.4× 306 2.7× 70 0.7× 15 615

Countries citing papers authored by A Bertasso

Since Specialization
Citations

This map shows the geographic impact of A Bertasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bertasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bertasso more than expected).

Fields of papers citing papers by A Bertasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Bertasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bertasso. The network helps show where A Bertasso may publish in the future.

Co-authorship network of co-authors of A Bertasso

This figure shows the co-authorship network connecting the top 25 collaborators of A Bertasso. A scholar is included among the top collaborators of A Bertasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Bertasso. A Bertasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gane, Edward, Paul J. Pockros, Stefan Zeuzem, et al.. (2014). Mericitabine and ritonavir‐boosted danoprevir with or without ribavirin in treatment‐naive HCV genotype 1 patients: INFORM ‐ SVR study. Liver International. 35(1). 79–89. 23 indexed citations
2.
Rodríguez‐Torres, M., Jihad Slim, Laveeza Bhatti, et al.. (2012). Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial. HIV Clinical Trials. 13(3). 142–152. 49 indexed citations
3.
Cooper, DA, Peter Reiss, Keith Henry, et al.. (2010). The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy*. HIV Medicine. 12(1). 31–39. 12 indexed citations
4.
Rodríguez‐Torres, M., Laveeza Bhatti, Richard K. Sterling, et al.. (2010). 296 PEGINTERFERON ALFA-2A (40KD) PLUS 800 OR 1000/1200 MG/DAY RBV IN G1 HIV-HCV-CO-INFECTED PATIENTS: EARLY RESPONSES TO TREATMENT AND PREDICTABILITY FOR SVR IN THE PARADIGM STUDY. Journal of Hepatology. 52. S124–S124. 1 indexed citations
5.
Alten, R., Cristiano A. F. Zerbini, Sławomir Jeka, et al.. (2009). Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy. Annals of the Rheumatic Diseases. 69(2). 364–367. 49 indexed citations
6.
Rockstroh, Jürgen K., Edwin DeJesus, Cynthia Wat, et al.. (2008). Adherence to Enfuvirtide and Its Impact on Treatment Efficacy. AIDS Research and Human Retroviruses. 24(2). 141–148. 4 indexed citations
7.
Wiznia, Andrew, Joseph A. Church, Patricia Emmanuel, et al.. (2007). Safety and Efficacy of Enfuvirtide for 48 Weeks as Part of an Optimized Antiretroviral Regimen in Pediatric Human Immunodeficiency Virus 1-Infected Patients. The Pediatric Infectious Disease Journal. 26(9). 799–805. 17 indexed citations
8.
Zhang, Xiaoping, A Bertasso, Claire F. Evans, et al.. (2007). Population Pharmacokinetics of Enfuvirtide in HIV‐1‐Infected Pediatric Patients Over 48 Weeks of Treatment. The Journal of Clinical Pharmacology. 47(4). 510–517. 11 indexed citations
9.
Dorr, Albert, et al.. (2005). Pharmacokinetics (PK) and pharmacodynamics (PD) of enfuvirtide in HIV-1-infected children over 24 weeks of treatment. Clinical Pharmacology & Therapeutics. 77(2). P59–P59. 3 indexed citations
10.
Bellibas, S. Eralp, Albert Dorr, A Bertasso, et al.. (2004). Pharmacokinetics of Enfuvirtide in Pediatric Human Immunodeficiency Virus 1-Infected Patients Receiving Combination Therapy. The Pediatric Infectious Disease Journal. 23(12). 1137–1141. 20 indexed citations
11.
Chapman, Jack, A Bertasso, Leda M. Cummings, & N H Georgopapadakou. (1995). Low-level resistance to the cephalosporin 3'-quinolone ester Ro 23-9424 in Escherichia coli. Antimicrobial Agents and Chemotherapy. 39(2). 564–566. 4 indexed citations
12.
Bertasso, A, et al.. (1993). Porins and lipopolysaccharide ofEscherichia coliATCC 25922 and isogenic rough mutants. FEMS Microbiology Letters. 108(2). 183–187. 9 indexed citations
13.
Georgopapadakou, N H & A Bertasso. (1993). Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli. Antimicrobial Agents and Chemotherapy. 37(3). 559–565. 20 indexed citations
14.
Bertasso, A, et al.. (1992). Screening assays for protein synthesis inhibitors.. The Journal of Antibiotics. 45(10). 1697–1699. 8 indexed citations
15.
Georgopapadakou, N H & A Bertasso. (1992). Effects of squalene epoxidase inhibitors on Candida albicans. Antimicrobial Agents and Chemotherapy. 36(8). 1779–1781. 24 indexed citations
16.
Bertasso, A, et al.. (1992). Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 36(8). 1601–1605. 35 indexed citations
17.
Pace, John, A Bertasso, & N H Georgopapadakou. (1991). Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424. Antimicrobial Agents and Chemotherapy. 35(5). 910–915. 16 indexed citations
18.
Georgopapadakou, N H & A Bertasso. (1991). Effects of quinolones on nucleoid segregation in Escherichia coli. Antimicrobial Agents and Chemotherapy. 35(12). 2645–2648. 14 indexed citations
19.
Georgopapadakou, N H, A Bertasso, Jack Chapman, et al.. (1989). Mode of action of the dual-action cephalosporin Ro 23-9424. Antimicrobial Agents and Chemotherapy. 33(7). 1067–1071. 35 indexed citations
20.
Kreis, Willi, et al.. (1980). Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture.. PubMed. 40(3). 634–41. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Chaniewski Breakdown of academic impact, for papers by Sanjay Khandekar Breakdown of academic impact, for papers by Joan Zugay-Murphy Breakdown of academic impact, for papers by Xinfeng Xu Breakdown of academic impact, for papers by Muhammad Hasan Breakdown of academic impact, for papers by Inna L. Karpenko Breakdown of academic impact, for papers by Phisit Prapunwattana Breakdown of academic impact, for papers by M Zawada Breakdown of academic impact, for papers by Juliane Gentzsch Breakdown of academic impact, for papers by Aditya Venugopal
Rankless by CCL
2026